Cargando…
Why the application of IVIG might be beneficial in patients with COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806196/ https://www.ncbi.nlm.nih.gov/pubmed/35120611 http://dx.doi.org/10.1016/S2213-2600(21)00549-X |
| _version_ | 1784643388500344832 |
|---|---|
| author | Kindgen-Milles, Detlef Feldt, Torsten Jensen, Bjoern Erik Ole Dimski, Thomas Brandenburger, Timo |
| author_facet | Kindgen-Milles, Detlef Feldt, Torsten Jensen, Bjoern Erik Ole Dimski, Thomas Brandenburger, Timo |
| author_sort | Kindgen-Milles, Detlef |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8806196 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88061962022-02-02 Why the application of IVIG might be beneficial in patients with COVID-19 Kindgen-Milles, Detlef Feldt, Torsten Jensen, Bjoern Erik Ole Dimski, Thomas Brandenburger, Timo Lancet Respir Med Correspondence Elsevier Ltd. 2022-02 2022-02-01 /pmc/articles/PMC8806196/ /pubmed/35120611 http://dx.doi.org/10.1016/S2213-2600(21)00549-X Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Kindgen-Milles, Detlef Feldt, Torsten Jensen, Bjoern Erik Ole Dimski, Thomas Brandenburger, Timo Why the application of IVIG might be beneficial in patients with COVID-19 |
| title | Why the application of IVIG might be beneficial in patients with COVID-19 |
| title_full | Why the application of IVIG might be beneficial in patients with COVID-19 |
| title_fullStr | Why the application of IVIG might be beneficial in patients with COVID-19 |
| title_full_unstemmed | Why the application of IVIG might be beneficial in patients with COVID-19 |
| title_short | Why the application of IVIG might be beneficial in patients with COVID-19 |
| title_sort | why the application of ivig might be beneficial in patients with covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806196/ https://www.ncbi.nlm.nih.gov/pubmed/35120611 http://dx.doi.org/10.1016/S2213-2600(21)00549-X |
| work_keys_str_mv | AT kindgenmillesdetlef whytheapplicationofivigmightbebeneficialinpatientswithcovid19 AT feldttorsten whytheapplicationofivigmightbebeneficialinpatientswithcovid19 AT jensenbjoernerikole whytheapplicationofivigmightbebeneficialinpatientswithcovid19 AT dimskithomas whytheapplicationofivigmightbebeneficialinpatientswithcovid19 AT brandenburgertimo whytheapplicationofivigmightbebeneficialinpatientswithcovid19 |